Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?

Journal of Gastrointestinal Surgery

Volumn 14, Issue 2, 2010, Pages 261-267

  Konstantinidis, Ioannis T ^a   Deshpande, Vikram ^a   Zheng, Hui ^a   Wargo, Jennifer A ^a   Castillo, Carlos Fernandez del ^a   Thayer, Sarah P ^a   Androutsopoulos, Vasiliki ^a   Lauwers, Gregory Y ^a   Warshaw, Andrew L ^a   Ferrone, Cristina R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Wang Ambulatory Care Center   (United States)

Author keywords

Direct lymph node invasion; Lymph node ratio; Pancreatic ductal adenocarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77951909986     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1096-z     Document Type: Article

References (21)

1. American Cancer Society www. cancer. org.
2. Ferrone CR, Brennan MF, Gonen M et al. Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg 2008; 12(4): 701-706.
3. Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006; 10(9): 1199-210. discussion 1210-1.
4. Schnelldorfer T, Ware AL, Sarr MG et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 2008; 247(3): 456-462.
5. Cleary SP, Gryfe R, Guindi M et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004; 198(5): 722-731.
6. House MG, Gonen M, Jarnagin WR et al. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 2007; 11(11): 1549-1555.
7. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003; 237(1): 74-85.
8. Ishikawa O, Ohigashi H, Sasaki Y et al. Practical grouping of positive lymph nodes in pancreatic head cancer treated by an extended pancreatectomy. Surgery 1997; 121(3): 244-249.
9. Pedrazzoli S, DiCarlo V, Dionigi R et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998; 228(4): 508-517.
10. Yeo CJ, Cameron JL, Lillemoe KD et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236(3): 355-366. discussion 366-8.
11. Farnell MB, Pearson RK, Sarr MG et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005; 138(4): 618-628. discussion 628-30.
12. Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 2006; 13(9): 1189-1200.
13. Pawlik TM, Gleisner AL, Cameron JL et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141(5): 610-618.
14. Tomlinson JS, Jain S, Bentrem DJ et al. Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg 2007; 142(8): 767-723. discussion 773-4.
15. Hellan M, Sun CL, Artinyan A et al. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer. Pancreas 2008; 37(1): 19-24.
16. Wilson M, Rosato EL, Chojnacki KA et al. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res 2008; 146(1): 11-15.
17. Inoue K, Nakane Y, Iiyama H et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002; 9(1): 27-34.
18. Nitti D, Marchet A, Olivieri M et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003; 10(9): 1077-1085.
19. Le Voyer TE, Sigurdson ER, Hanlon AL et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21(15): 2912-2919.
20. Berger AC, Watson JC, Ross EA, Hoffman JP. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 2004; 70(3): 235-240. discussion 240.
21. Smith RA, Bosonnet L, Ghaneh P et al. Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. Dig Surg 2008; 25(3): 226-232.